Arrowhead Pharmaceuticals Inc (ARWR)
Financial leverage ratio
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total assets | US$ in thousands | 1,139,800 | 883,759 | 955,150 | 626,286 | 765,552 | 795,856 | 891,308 | 891,489 | 691,939 | 751,782 | 703,575 | 638,539 | 710,148 | 734,927 | 756,795 | 499,251 | 522,504 | 555,728 | 561,076 | 587,602 |
Total stockholders’ equity | US$ in thousands | 185,444 | 330,547 | 483,794 | 160,407 | 271,343 | 364,830 | 446,772 | 377,039 | 398,520 | 453,927 | 452,266 | 372,560 | 408,822 | 436,890 | 445,549 | 454,472 | 461,779 | 493,140 | 494,119 | 500,084 |
Financial leverage ratio | 6.15 | 2.67 | 1.97 | 3.90 | 2.82 | 2.18 | 1.99 | 2.36 | 1.74 | 1.66 | 1.56 | 1.71 | 1.74 | 1.68 | 1.70 | 1.10 | 1.13 | 1.13 | 1.14 | 1.18 |
September 30, 2024 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,139,800K ÷ $185,444K
= 6.15
The financial leverage ratio of Arrowhead Pharmaceuticals Inc has shown fluctuations over the past few quarters. The ratio measures the extent to which the company utilizes debt to finance its operations and investments. A higher ratio indicates a higher level of financial risk due to increased debt obligations.
Looking at the data provided, the financial leverage ratio has been trending upwards since the end of 2019, reaching a peak of 6.15 at the end of September 2024. This significant increase in the ratio suggests a considerable increase in the company's debt relative to its equity over this period.
It is important to note that a high financial leverage ratio can indicate a higher level of financial risk for the company, as it may struggle to meet its debt obligations, especially in times of economic uncertainty or a downturn in the industry. On the other hand, a low financial leverage ratio is usually considered less risky as the company is less reliant on debt financing.
Overall, the trend of Arrowhead Pharmaceuticals Inc's financial leverage ratio indicates a shift towards a higher level of debt in its capital structure in recent quarters. This could potentially expose the company to increased financial risk and impact its overall financial stability and flexibility. It would be important for stakeholders to closely monitor the company's debt levels and management strategies to ensure sustainable financial performance in the future.
Peer comparison
Sep 30, 2024